NKTR- Nektar Therapeutics

Insider activity in NKTR over the last quarter tilts toward selling: insiders offloaded a net 5,538 shares worth roughly $336K.

Classified under Biotechnology (Health Care sector), NKTR's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robin Howard W	57.2K	$4.37M	-
Other	Wilson Mark Andrew	21.6K	$1.65M	-
Other	Zalevsky Jonathan	16.5K	$1.26M	-
Dir	Ajer Jeffrey Robert	8.0K	$611.8K	-
Dir	Greer R Scott	8.0K	$611.8K	-

Buys and sells only

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 16, 2022	Labrucherie Gil M84	SVP, COO &CFO	Sell	17,448	$3.95	$68,919.60	-5.3%	+26.5%	-81.6%
Feb 16, 2022	Zalevsky Jonathan63	Chief R&D Officer	Sell	10,912	$10.95	$119,486.40	-3.8%	-64.8%	-73.4%
Feb 16, 2022	Wilson Mark Andrew58	SVP &General Counsel	Sell	3,661	$10.95	$40,087.95	-2.9%	-64.8%	-73.4%
Feb 16, 2022	Thomsen Jillian B.86	SVP &Chief Accounting Officer	Sell	2,363	$10.95	$25,874.85	-1.4%	-64.8%	-73.4%
Feb 16, 2022	Robin Howard W58	President &CEO	Sell	12,480	$10.95	$136,656.00	-2.1%	-64.8%	-73.4%
Feb 16, 2022	Northcott John79	SVP &Chief Commercial Officer	Sell	4,852	$10.95	$53,129.40	-2.1%	-64.8%	-73.4%
Feb 16, 2022	Labrucherie Gil M84	SVP, COO &CFO	Sell	7,579	$10.95	$82,990.05	-2.5%	-64.8%	-73.4%
Nov 18, 2021	Labrucherie Gil M84	SVP, COO &CFO	Sell	24,149	$13.10	$316,390.84	-4.5%	-4.8%	-70.3%
Nov 16, 2021	Northcott John79	SVP &Chief Commercial Officer	Sell	6,061	$13.16	$79,762.76	-3.0%	-18.3%	-73.5%
Nov 16, 2021	Zalevsky Jonathan63	Chief R&D Officer	Sell	20,869	$13.16	$274,636.04	-8.3%	-18.3%	-73.5%